Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone.
暂无分享,去创建一个
L Zhi | C M Tegley | K B Marschke | T K Jones | T. K. Jones | C. Tegley | K. Marschke | L. Zhi
[1] P. Fail,et al. Reversal of activity profile in analogs of the antiprogestin RU 486: effect of a 16 alpha-substituent on progestational (agonist) activity. , 1993, Life sciences.
[2] L. Hamann,et al. Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071). , 1999, Journal of medicinal chemistry.
[3] G. Reynolds,et al. Reactions of β-Keto Esters with Aromatic Amines. Syntheses of 2- and 4-Hydroxyquinoline Derivatives1 , 1948 .
[4] P. Schellhammer,et al. Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group. , 1997, Urology.
[5] J. Edwards,et al. New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone. , 1998, Bioorganic & medicinal chemistry letters.
[6] A. Wakeling,et al. Novel steroidal pure antiestrogens , 1989, Steroids.
[7] J. Edwards,et al. Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one. , 1999, Bioorganic & medicinal chemistry letters.
[8] J. Edwards,et al. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines. , 1998, Journal of medicinal chemistry.